help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2003-0331
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/2/269    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lange, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lange, C. A.
Molecular Endocrinology 18 (2): 269-278
Copyright © 2004 by The Endocrine Society


Minireview

Making Sense of Cross-Talk between Steroid Hormone Receptors and Intracellular Signaling Pathways: Who Will Have the Last Word?

Carol A. Lange

University of Minnesota Cancer Center, Departments of Medicine (Division of Hematology, Oncology, and Transplant) and Pharmacology, Minneapolis Minnesota 55455

Address all correspondence and requests for reprints to: C. A. Lange, University of Minnesota Cancer Center, Departments of Medicine (Division of Hematology, Oncology, and Transplant) and Pharmacology, Minneapolis Minnesota 55455. E-mail: Lange047{at}tc.umn.edu.

In classical models of nuclear steroid hormone receptor function, ligand binds receptor, heat shock proteins dissociate, and receptor dimers enter or are withheld in the nucleus and interact with coregulatory molecules to mediate changes in gene expression. The footnotes, "receptors become phosphorylated" and "dynamic nucleo-cytoplasmic shuttling occurs" describe well-accepted, but less well-understood aspects of receptor action. Recently, the idea that several protein kinases are activated in response to steroid hormone binding to cognate cytoplasmic or membrane-associated receptors has become fashionable. However, the precise role of steroid hormone receptor phosphorylation and our understanding of which cytoplasmic kinases are activated and their functional significance remain elusive. This review provides an overview of the primary ways in which steroid hormone receptor and growth factor cross-talk occurs, using the human progesterone receptor (PR) as a model. The functional consequences of PR phosphorylation by protein kinases classically activated in response to peptide growth factors and novel extranuclear or nongenomic functions of PR as potential independent initiators of signal transduction pathways are discussed. Intracellular protein kinases are emerging as key mediators of steroid hormone receptor action. Cross-talk between steroid receptor- and growth factor-initiated signaling events may explain how gene subsets are coordinately regulated by mitogenic stimuli in hormonally responsive normal tissues, and is suspected to play a role in their cancer biology.

NURSA Molecule Pages Link:

Nuclear Receptors:   PR
Coregulators:   SRC-1  |  PELP1
Ligands:   Progesterone



This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
J. E Morabito, J. F Trott, D. M Korz, H. E Fairfield, S. H Buck, and R. C Hovey
A 5' distal palindrome within the mouse mammary tumor virus-long terminal repeat recruits a mammary gland-specific complex and is required for a synergistic response to progesterone plus prolactin
J. Mol. Endocrinol., August 1, 2008; 41(2): 75 - 90.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Belakavadi, P. K. Pandey, R. Vijayvargia, and J. D. Fondell
MED1 Phosphorylation Promotes Its Association with Mediator: Implications for Nuclear Receptor Signaling
Mol. Cell. Biol., June 15, 2008; 28(12): 3932 - 3942.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Mani
Progestin Receptor Subtypes in the Brain: The Known and the Unknown
Endocrinology, June 1, 2008; 149(6): 2750 - 2756.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. J. Peluso, X. Liu, M. M. Saunders, K. P. Claffey, and K. Phoenix
Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1592 - 1599.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. M. Silva and M. A. Shupnik
Integration of Steroid and Growth Factor Pathways in Breast Cancer: Focus on Signal Transducers and Activators of Transcription and Their Potential Role in Resistance
Mol. Endocrinol., July 1, 2007; 21(7): 1499 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. P. Carnevale, C. J. Proietti, M. Salatino, A. Urtreger, G. Peluffo, D. P. Edwards, V. Boonyaratanakornkit, E. H. Charreau, E. B. de Kier Joffe, R. Schillaci, et al.
Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone Receptor Capacity to Activate Cytoplasmic Signaling Pathways
Mol. Endocrinol., June 1, 2007; 21(6): 1335 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C.-S. Yang, H.-W. Xin, J. B. Kelley, A. Spencer, D. L. Brautigan, and B. M. Paschal
Ligand Binding to the Androgen Receptor Induces Conformational Changes That Regulate Phosphatase Interactions
Mol. Cell. Biol., May 1, 2007; 27(9): 3390 - 3404.
[Abstract] [Full Text] [PDF]


Home page
Adv. Physiol. Educ.Home page
M. E. Wierman
Sex steroid effects at target tissues: mechanisms of action
Advan Physiol Educ, March 1, 2007; 31(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Cascio, V. Bartella, C. Garofalo, A. Russo, A. Giordano, and E. Surmacz
Insulin-like Growth Factor 1 Differentially Regulates Estrogen Receptor-dependent Transcription at Estrogen Response Element and AP-1 Sites in Breast Cancer Cells
J. Biol. Chem., February 9, 2007; 282(6): 3498 - 3506.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. L. Arnett-Mansfield, J. D. Graham, A. R. Hanson, P. A. Mote, A. Gompel, L. L. Scurr, N. Gava, A. de Fazio, and C. L. Clarke
Focal Subnuclear Distribution of Progesterone Receptor Is Ligand Dependent and Associated with Transcriptional Activity
Mol. Endocrinol., January 1, 2007; 21(1): 14 - 29.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S. C. Teilmann, C. A. Clement, J. Thorup, A. G. Byskov, and S. T. Christensen
Expression and localization of the progesterone receptor in mouse and human reproductive organs
J. Endocrinol., December 1, 2006; 191(3): 525 - 535.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, B. M. Necela, W. Su, M. Yanagisawa, P. Z. Anastasiadis, A. P. Fields, and E. A. Thompson
Peroxisome Proliferator-activated Receptor {gamma} Promotes Epithelial to Mesenchymal Transformation by Rho GTPase-dependent Activation of ERK1/2
J. Biol. Chem., August 25, 2006; 281(34): 24575 - 24587.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B.-S. An, D. M. Selva, G. L. Hammond, A. Rivero-Muller, N. Rahman, and P. C. K. Leung
Steroid Receptor Coactivator-3 Is Required for Progesterone Receptor Trans-activation of Target Genes in Response to Gonadotropin-releasing Hormone Treatment of Pituitary Cells
J. Biol. Chem., July 28, 2006; 281(30): 20817 - 20824.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Wang, N. Ohara, Z. Wang, W. Chen, A. Morikawa, H. Sasaki, D. A. DeManno, K. Chwalisz, and T. Maruo
A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells
Hum. Reprod., July 1, 2006; 21(7): 1869 - 1877.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. N. Jabbour, R. W. Kelly, H. M. Fraser, and H. O. D. Critchley
Endocrine Regulation of Menstruation
Endocr. Rev., February 1, 2006; 27(1): 17 - 46.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Goldman and E. Shalev
Difference in Progesterone-Receptor Isoforms Ratio Between Early and Late First-Trimester Human Trophoblast Is Associated with Differential Cell Invasion and Matrix Metalloproteinase 2 Expression
Biol Reprod, January 1, 2006; 74(1): 13 - 22.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. Uchida, T. Maruyama, T. Nagashima, H. Asada, and Y. Yoshimura
Histone Deacetylase Inhibitors Induce Differentiation of Human Endometrial Adenocarcinoma Cells through Up-Regulation of Glycodelin
Endocrinology, December 1, 2005; 146(12): 5365 - 5373.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Sayasith, J. G. Lussier, and J. Sirois
Role of Upstream Stimulatory Factor Phosphorylation in the Regulation of the Prostaglandin G/H Synthase-2 Promoter in Granulosa Cells
J. Biol. Chem., August 12, 2005; 280(32): 28885 - 28893.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Grossmann, A. Benesic, A. W. Krug, R. Freudinger, S. Mildenberger, B. Gassner, and M. Gekle
Human Mineralocorticoid Receptor Expression Renders Cells Responsive for Nongenotropic Aldosterone Actions
Mol. Endocrinol., July 1, 2005; 19(7): 1697 - 1710.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Nishiyama, L. Yao, Y. Fan, M. Kyaw, N. Kataoka, K. Hashimoto, Y. Nagai, E. Nakamura, M. Yoshizumi, T. Shokoji, et al.
Involvement of Aldosterone and Mineralocorticoid Receptors in Rat Mesangial Cell Proliferation and Deformability
Hypertension, April 1, 2005; 45(4): 710 - 716.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C.-S. Yang, M. J. Vitto, S. A. Busby, B. A. Garcia, C. T. Kesler, D. Gioeli, J. Shabanowitz, D. F. Hunt, K. Rundell, D. L. Brautigan, et al.
Simian Virus 40 Small t Antigen Mediates Conformation-Dependent Transfer of Protein Phosphatase 2A onto the Androgen Receptor
Mol. Cell. Biol., February 15, 2005; 25(4): 1298 - 1308.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Skildum, E. Faivre, and C. A. Lange
Progesterone Receptors Induce Cell Cycle Progression via Activation of Mitogen-Activated Protein Kinases
Mol. Endocrinol., February 1, 2005; 19(2): 327 - 339.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Wu, S. Brandt, and S. M. Hyder
Ligand- and Cell-Specific Effects of Signal Transduction Pathway Inhibitors on Progestin-Induced Vascular Endothelial Growth Factor Levels in Human Breast Cancer Cells
Mol. Endocrinol., February 1, 2005; 19(2): 312 - 326.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Narayanan, A. A. Adigun, D. P. Edwards, and N. L. Weigel
Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin A/Cdk2 as a Progesterone Receptor Coactivator
Mol. Cell. Biol., January 1, 2005; 25(1): 264 - 277.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. K. Pierson-Mullany and C. A. Lange
Phosphorylation of Progesterone Receptor Serine 400 Mediates Ligand-Independent Transcriptional Activity in Response to Activation of Cyclin-Dependent Protein Kinase 2
Mol. Cell. Biol., December 15, 2004; 24(24): 10542 - 10557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society